| abstract |
The invention discloses a medicine for treating diabetic gangrene, which comprises the following raw material medicines in parts by weight: 30-35 parts of fructus amomi; 22-24 parts of bletilla striata; 15-18 parts of bighead atractylodes rhizome; 10-14 parts of dioscorea cirrhosa. The medicine for treating diabetic gangrene provided by the invention takes fructus amomi, bletilla striata, bighead atractylodes rhizome, dioscorea cirrhosa, frangipani, hypericum japonicum, radix sophorae flavescentis, uniflower swisscentaury root and lotus leaves as raw materials, and the extraction of the raw materials is carried out by combining low-temperature wall breaking and extraction purification, so that the medicine has the effects of reducing swelling and easing pain, promoting the wound surface to heal quickly, and the cure rate of diabetic gangrene reaches more than 88%, and the diabetic gangrene is high in cure rate and does not relapse. |